Cruzain: Difference between revisions

Michal Harel (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
 
(10 intermediate revisions by 2 users not shown)
Line 1: Line 1:
<StructureSection load='1me3' size='350' side='right' caption='Structure of cruzain catalytic domain complex with methylketone inhibitor (PDB entry [[1me3]])' scene=''>
<StructureSection load='1me3' size='350' side='right' caption='Structure of cruzain catalytic domain complex with methylketone inhibitor (PDB entry [[1me3]])' scene='51/517378/Cv/1'>


'''Cruzain''' (Cru) is the major cysteine protease present in ''Trypanosoma cruzi'' which is the parasite causing Chagas disease. <ref>PMID:10997902</ref>  
'''Cruzain''' or '''cruzipain''' (Cru) is the major cysteine protease present in ''Trypanosoma cruzi'' which is the parasite causing Chagas disease. <ref>PMID:10997902</ref>  


== Relevance ==
== Relevance ==


Cru inhibitors are being investigated for therapeutic use against Chagas disease.
Cru inhibitors are being investigated for therapeutic use against Chagas disease.
== Structural highlights ==
<scene name='51/517378/Cv/5'>Cru catalytic triad is Cys-His-Asn</scene> and <scene name='51/517378/Cv/6'>whole binding site</scene> ([[1me3]]).<ref>PMID:12467703</ref>


</StructureSection>
</StructureSection>
Line 12: Line 16:
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}


[[1aim]], [[2aim]], [[1me3]], [[1me4]] –  Cru catalytic domain + methylketone inhibitor – ''Trypanosoma cruzi''<br />
[[6n3s]] - TcCru catalytic domain 123-337 - ''Trypanosoma cruzi'' <br />
[[1f29]], [[1f2a]], [[1f2b]], [[1f2c]], [[1ewo]], [[3lxs]] - Cru catalytic domain + vinyl sulfone derived inhibitor<br />
[[1aim]], [[2aim]], [[1me3]], [[1me4]], [[3iut]] –  TcCru catalytic domain + methylketone inhibitor<br />
[[1ewl]], [[1ewm]] – Cru catalytic domain + methylbutane inhibitor<br />
[[1f29]], [[1f2a]], [[1f2b]], [[1f2c]], [[1ewo]], [[2oz2]], [[3hd3]], [[3lxs]], [[6ux6]] - TcCru catalytic domain + vinyl sulfone derived inhibitor<br />
[[1ewp]] - Cru catalytic domain + MOR-Leu-HPQ<br />
[[1ewl]], [[1ewm]] – TcCru catalytic domain + methylbutane inhibitor<br />
[[1u9q]], [[3i06]], [[3kku]], [[4klb]], [[4pi3]], [[4qh6]], [[4w5b]], [[4w5c]], [[4xui]], [[6o2x]] - TcCru catalytic domain + inhibitor<br />
[[1ewp]] - TcCru catalytic domain + MOR-Leu-HPQ<br />
[[4w5b]], [[4xui]], [[4qh6]], [[4pi3]], [[4klb]], [[3kku]], [[3i06]], [[2oz2]], [[1u9q]] – TcCru + inhibitor <br />
[[4w5c]], [[3iut]], [[3hd3]] – TcCru (mutant) + inhibitor <br />
[[7juj]], [[7s18]], [[7s19]] - TcCru catalytic domain + gallinamide derivative<br />
== References ==
== References ==
<references/>
<references/>

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky